Favourites   Have ideas?  Sign in / Register

Positive:   Cannabis ↓10.24   Reproductive health ↓8.49   Skin ↓7.79 «See more»   Healthcare ↑31.41   Disease: Cardiovascular ↑31.41   Country: Canada ↑38.49

Negative:   Bad infrastructure  ↓0.16


Cancer fight segment

ACET Adicet Bio, Inc. - Common Stock 10.72% 10.72% 0 + Medicine, Cancer fight

+ My List
ADAP Adaptimmune Therapeutics plc - American Depositary Shares -6.54% up -9.85% 3.31 + Medicine, Cancer fight


Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities
+ My List
AEMD Aethlon Medical, Inc. - Common Stock 2.82% down 7.04% -4.22 + Health Devices, Medicine, Cancer fight

+ My List
AFMD Affimed N.V. - Common Stock 8.39% up 6.04% 2.35 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock 8.75% 8.75% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AIKI AIkido Pharma Inc. - Common Stock -6.8% up -8.74% 1.94 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock 7.03% up 6.77% 0.26 + Cancer fight, Gene and cell, Medicine

+ My List
ALPN Alpine Immune Sciences, Inc. - Common Stock 1.33% down 12.76% -11.43 + Medicine, Cancer fight

+ My List
ALRN Aileron Therapeutics, Inc. - Common Stock -8.7% -8.7% 0 + Cancer fight, Medicine, Biopharma

+ My List
ALXO ALX Oncology Holdings Inc. - Common Stock 4.51% down 7.01% -2.5 + Medicine, Cancer fight

+ My List
ANAB AnaptysBio, Inc. - Common Stock -5.77% up -10.5% 4.73 + Immunology, Cancer fight, Medicine

+ My List
ANCN Anchiano Therapeutics Ltd. - American Depositary Shares 0.00% 0 + Cancer fight, Biopharma, Medicine, Country: Israel

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock 7.09% up 2.23% 4.86 + Cancer fight, Medicine, Immunology

+ My List
ANPC AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares 7.43% 7.43% 0 + Cancer fight


Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601
+ My List
APOP Cellect Biotechnology Ltd. - American Depositary Shares 6.02% down 7.57% -1.55 + Country: Israel, Cancer fight, Medicine

+ My List
APRE Aprea Therapeutics, Inc. - Common Stock 6.14% down 7.5% -1.36 + Medicine, Cancer fight


Last highlighted: Aprea Therapeutics Inc trading halted, news pending $APRE
+ My List
ARAV Aravive, Inc. - Common Stock -0.26% -0.26% 0 + Medicine, Cancer fight

+ My List
ATNX Athenex, Inc. - Common Stock 8.73% 8.73% 0 + Cancer fight, Biopharma, Covid (fighting)

+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares 7.23% up 5.16% 2.07 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -9.9% 9.9 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
AVEO AVEO Pharmaceuticals, Inc. - Common Stock 1.25% down 8.6% -7.35 + Medicine, Disease: Oncology, Cancer fight


Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137
+ My List
AWH Aspira Women's Health Inc. - Common Stock -2.07% -2.07% 0 + Cancer fight, Women Health, Medicine

+ My List
AYLA Ayala Pharmaceuticals, Inc. - Common Stock -18.73% -18.73% 0 + Medicine, Cancer fight

+ My List
BLRX BioLineRx Ltd. - American Depositary Shares 7.17% 7.17% 0 + Medicine, Cancer fight

+ My List
BNGO Bionano Genomics, Inc. - Common Stock 0.75% up -0.38% 1.13 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant 2.74% down 7.31% -4.57 + Cancer fight, Medicine, Gene and cell

+ My List
BNR Burning Rock Biotech Limited - American Depositary Shares -8.11% -8.11% 0 + Country: China, Cancer fight, Medicine

+ My List
BPTH Bio-Path Holdings, Inc. - Common Stock -8.64% up -8.8% 0.16 + Cancer fight, Medicine

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares -5.6% up -7.73% 2.13 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CALA Calithera Biosciences, Inc. - Common Stock -2.38% -2.38% 0 + Medicine, Cancer fight

+ My List
CBLI Cleveland BioLabs, Inc. - Common Stock -7.85% -7.85% 0 + Cancer fight

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -0.13% down 7.05% -7.18 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CELC Celcuity Inc. - Common Stock 4.65% down 9.24% -4.59 + Cancer fight, Medicine


Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754
+ My List
CGIX Cancer Genetics, Inc. - Common Stock -0.86% -0.86% 0 + Cancer fight, Medicine

+ My List
CKPT Checkpoint Therapeutics, Inc. - Common Stock -1.89% -1.89% 0 + Cancer fight, Medicine

+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 6.55% down 7.16% -0.61 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CLLS Cellectis S.A. - American Depositary Shares 5.94% down 7.14% -1.2 + Biopharma, Medicine, Cancer fight

+ My List
CLRB Cellectar Biosciences, Inc. - Common Stock -7.41% up -9.26% 1.85 + Medicine, Biopharma, Cancer fight


Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932
+ My List
CLSN Celsion Corporation - Common Stock 7.84% up 3.92% 3.92 + Cancer fight, Medicine

+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock -8.75% -8.75% 0 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 65.42% down 65.56% -0.14 + Cancer fight, Medicine, Pharmaceutical

+ My List
CRDF Cardiff Oncology, Inc. - Common Stock -0.3% down 8.23% -8.53 + Cancer fight, Medicine


Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042
+ My List
CRIS Curis, Inc. - Common Stock 7.22% down 7.36% -0.14 + Cancer fight, Medicine

+ My List
CSTL Castle Biosciences, Inc. - Common stock -2.18% up -7.37% 5.19 + Cancer fight, Medicine

+ My List
CTMX CytomX Therapeutics, Inc. - Common Stock 7.13% up 6.67% 0.46 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
+ My List
CUE Cue Biopharma, Inc. - Common Stock 1.62% down 7.56% -5.94 + Biopharma, Immunology, Cancer fight

+ My List
CYCCP Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 8.42% 8.42% 0 + Cancer fight, Medicine, Biopharma


Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c
+ My List
DCTH Delcath Systems, Inc. - Common Stock 8.4% up 7.29% 1.11 + Cancer fight, Medicine, Disease: Liver


Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness
+ My List
DMTK DermTech, Inc. - Common Stock -8.57% down -8.41% -0.16 + Medicine, Cancer fight, Skin


Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number
+ My List
DTIL Precision BioSciences, Inc. - Common Stock 2.43% down 8.68% -6.25 + Cancer fight, Gene and cell, Food

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock 11.29% down 11.43% -0.14 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
EPIX ESSA Pharma Inc. - Common Stock 0.7% down 8.31% -7.61 + Pharmaceutical , Country: Canada, Cancer fight


Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253
+ My List
EPZM Epizyme, Inc. - Common Stock -3.35% -3.35% 0 + Cancer fight, Gene and cell

+ My List
FATE Fate Therapeutics, Inc. - Common Stock -0.44% down 7.88% -8.32 + Cancer fight, Immunology, Medicine

+ My List
FGEN FibroGen, Inc - Common Stock 6.87% down 8.15% -1.28 + Medicine, Cancer fight, Respiratory therapies / Pulmanory

+ My List
FLDM Fluidigm Corporation - Common Stock 6.42% down 7.82% -1.4 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270
+ My List
FPRX Five Prime Therapeutics, Inc. - Common Stock 0.03% 0.03% 0 + Cancer fight, Medicine

+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares 9.29% 9.29% 0 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
GALT Galectin Therapeutics Inc. - Common Stock -7% up -7.25% 0.25 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679
+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 4.66% down 8.81% -4.15 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock 8.52% 8.52% 0 + Cancer fight, Immunology, Medicine

+ My List
GNPX Genprex, Inc. - Common Stock -8.48% down -7.27% -1.21 + Cancer fight, Disease: Oncology, Medicine


Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd
+ My List
GOVX GeoVax Labs, Inc. - Common Stock -10.19% down -9.77% -0.42 + Medicine, Cancer fight

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -2.77% down 10.35% -13.12 + Medicine, Immunology, Cancer fight

+ My List
GTH Genetron Holdings Limited - American Depositary Shares 1.78% down 8.02% -6.24 + Cancer fight, Medicine, Disease: Oncology, Country: China


Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL
+ My List
HCM Hutchison China MediTech Limited - American Depositary Shares 0.90% down 1.96% -1.06 + Country: China, Medicine, Disease: Oncology, Cancer fight


Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited https://t.co/3MQ4DYnXFz 15s delayed.
+ My List
HGEN Humanigen, Inc. - Common Stock -57.04% up -57.79% 0.75 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -1.42% down 7.18% -8.6 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTBX Heat Biologics, Inc. - Common Stock -9.58% -9.58% 0 + Medicine, Cancer fight

+ My List
ICAD icad inc. - Common Stock 7.03% down 8.56% -1.53 + Medicine, Devices, Cancer fight


Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock -8.49% up -9.67% 1.18 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IMMP Immutep Limited - American Depositary Shares -5.49% up -7.55% 2.06 + Cancer fight, Medicine

+ My List
IMNM Immunome, Inc. - Common Stock 12.2% 12.2% 0 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares 3.03% down 7.62% -4.59 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
INFI Infinity Pharmaceuticals, Inc. - Common Stock -0.89% down 7.21% -8.1 + Medicine, Cancer fight


Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock -8.74% up -9.26% 0.52 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -0.67% down 10.03% -10.7 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock 2.54% 2.54% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock 13.45% up 11.9% 1.55 + Immunology, Cancer fight, Medicine

+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock -7.15% -7.15% 0 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 13.1% up 8.33% 4.77 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KTRA Kintara Therapeutics, Inc. - Common Stock 2.27% down 9.09% -6.82 + Cancer fight, Medicine

+ My List
KURA Kura Oncology, Inc. - Common Stock -4% down 9.88% -13.88 + Cancer fight, Medicine


Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278
+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock -6.7% down 8.19% -14.89 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock 6.57% down 7.14% -0.57 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MGNX MacroGenics, Inc. - Common Stock -19.24% -19.24% 0 + Medicine, Cancer fight

+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock 8.16% 8.16% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MNPR Monopar Therapeutics Inc. - Common Stock 0.59% up -8.06% 8.65 + Cancer fight, Medicine, Biopharma


Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054
+ My List
MOR MorphoSys AG - American Depositary Shares 7.22% up 7.08% 0.14 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MREO Mereo BioPharma Group plc - American Depositary Shares 3.36% down 7.46% -4.1 + Biopharma, Cancer fight, Country: Greate Britain


Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904
+ My List
MRKR Marker Therapeutics, Inc. - Common Stock 7.14% down 9.34% -2.2 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
MRSN Mersana Therapeutics, Inc. - Common Stock -9.72% -9.72% 0 + Medicine, Cancer fight


Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number
+ My List
MRUS Merus N.V. - Common Shares -2.66% down 9.94% -12.6 + Cancer fight, Medicine, Country: Netherlands


Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220
+ My List
NCNA NuCana plc - American Depositary Shares 7.11% up 5.86% 1.25 + Cancer fight, Disease: Oncology, Medicine

+ My List
NH NantHealth, Inc. - Common Stock -7.62% -7.62% 0 + Cancer fight, Medicine
- Bad infrastructure
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock 6.06% down 8.27% -2.21 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
NVCR NovoCure Limited - Ordinary Shares 0.31% 0.31% 0 + Cancer fight, Medicine

+ My List
ODT Odonate Therapeutics, Inc. - Common Stock 10% down 10.67% -0.67 + Cancer fight, Medicine


Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890
+ My List
ONCR Oncorus, Inc. - Common Stock -8.47% down -7.81% -0.66 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock -8.26% -8.26% 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares -2.15% down 12.56% -14.71 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock 48.99% 48.99% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 4.86% down 7.35% -2.49 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock 8.49% up 2.83% 5.66 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -4.22% down 11.62% -15.84 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock 0.32% up -7.71% 8.03 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
POAI Predictive Oncology Inc. - Common Stock 5.77% down 8.65% -2.88 + Cancer fight, Medicine, Artificial Intelligence


Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number
+ My List
PRLD Prelude Therapeutics Incorporated - Common Stock up -8.01% 8.01 + Cancer fight, Medicine


Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number
+ My List
PROG Progenity, Inc. - Common Stock -2.91% up -10.81% 7.9 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PSTV PLUS THERAPEUTICS, Inc. - Common Stock -1.52% up -11.61% 10.09 + Cancer fight, Medicine, Radiotherapy


Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)]
+ My List
QTRX Quanterix Corporation - Common Stock 31.41% up 31.41 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology


Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number
+ My List
RAPT RAPT Therapeutics, Inc. - Common Stock 6.99% down 7.08% -0.09 + Cancer fight, Medicine


Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number
+ My List
REPL Replimune Group, Inc. - Common Stock 6.74% down 8.24% -1.5 + Cancer fight


Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number
+ My List
RIGL Rigel Pharmaceuticals, Inc. - Common Stock 1.47% down 8.36% -6.89 + Medicine, Cancer fight

+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock down 7.85% -7.85 + Gene and cell, Cancer fight, Medicine

+ My List
RVMD Revolution Medicines, Inc. - Common Stock 3.5% up -8.48% 11.98 + Cancer fight, Medicine, Biotechnology

+ My List
SESN Sesen Bio, Inc. - Common Stock 5% down 7% -2 + Cancer fight, Medicine


Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock -0.97% -0.97% 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SLS SELLAS Life Sciences Group, Inc. - Common Stock 9.26% up 5.36% 3.9 + Cancer fight, Medicine


Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx
+ My List
SNSS Sunesis Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Biopharma, Cancer fight

+ My List
SONN Sonnet BioTherapeutics Holdings, Inc. - Common Stock -45.05% down -44.14% -0.91 + Cancer fight, Biology, Medicine

+ My List
SRNE Sorrento Therapeutics, Inc. - Common Stock 6.56% down 8% -1.44 + Pain fight, Cancer fight, Medicine

+ My List
STRO Sutro Biopharma, Inc. - Common Stock -0.1% down 8.09% -8.19 + Cancer fight, Medicine

+ My List
SURF Surface Oncology, Inc. - Common Stock 13.37% 13.37% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock -5.03% up -10.06% 5.03 + Gene and cell, Medicine, Cancer fight

+ My List
TARA Protara Therapeutics, Inc. - Common Stock -5.98% up -7.2% 1.22 + Cancer fight, Medicine

+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock 3.28% down 11.48% -8.2 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TCRR TCR2 Therapeutics Inc. - Common Stock 1.38% up -10.44% 11.82 + Cancer fight, Medicine

+ My List
THTX Theratechnologies Inc. - Common Shares -6.65% down 8.31% -14.96 + Cancer fight, Biopharma, Medicine

+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 189.49% down 189.66% -0.16999999999999 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
TTOO T2 Biosystems, Inc. - Common Stock -5.88% up -7.84% 1.96 + Medicine, Cancer fight


Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number
+ My List
TYME Tyme Technologies, Inc. - Common Stock 4.9% down 7.84% -2.94 + Cancer fight, Medicine


Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number
+ My List
VBLT Vascular Biogenics Ltd. - Ordinary Shares -2.55% down 7.8% -10.35 + Country: Israel, Biopharma, Cancer fight, Medicine

+ My List
VERU Veru Inc. - Common Stock -1.52% down 9.99% -11.51 + Cancer fight, Medicine


Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript
+ My List
VRAY ViewRay, Inc. - Common Stock 3.38% down 9.2% -5.82 + Cancer fight, Radiotherapy, Medicine


Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242
+ My List
VSTM Verastem, Inc. - Common Stock 6.02% down 8.43% -2.41 + Biopharma, Cancer fight, Medicine


Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620
+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock -6.77% up -7.42% 0.65 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock 4.55% up -8.7% 13.25 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
YMAB Y-mAbs Therapeutics, Inc. - Common Stock 0.03% down 7.31% -7.28 + Biopharma, Cancer fight, Medicine


Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -1.79% up -10.44% 8.65 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 9.19% 9.19% 0 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 5.31% down 7.41% -2.1 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -9.19% -9.19% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.24% down -4.78% -5.46 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.95% -7.95% 0 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock 1.05% down 12.63% -11.58 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock -9.77% down -7.91% -1.86 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock 1.78% up -7.41% 9.19 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
OCX OncoCyte Corporation - Common Stock 7.27% up 6.52% 0.75 + Cancer fight, Diagnosing, Medicine


Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996
+ My List
PPBT Purple Biotech Ltd. - American Depositary Shares -7.69% down -1.81% -5.88 + Country: Israel, Cancer fight, Disease: Oncology

+ My List
PRTG Portage Biotech Inc. - Common Stock -4.87% up -7.37% 2.5 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
SBTX Silverback Therapeutics, Inc. - Common Stock -18.27% -18.27% 0 + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 3.12% down 8.41% -5.29 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
VOR Vor Biopharma Inc. - Common Stock 7.18% up 4.98% 2.2 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
IKNA Ikena Oncology, Inc. - Common Stock 10.27% 10.27% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -7.92% down -3.44% -4.48 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.